Neha Patil (Editor)

Flexion Therapeutics

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Type  Public
Industry  Biotechnology
Founded  2007
Traded as  NASDAQ: FLXN
Website  Flexion Therapeutics
Flexion Therapeutics httpscrunchbaseproductionrescloudinarycomi
Stock price  FLXN (NASDAQ) US$ 20.73 +0.10 (+0.48%)10 Mar, 4:00 PM GMT-5 - Disclaimer
Headquarters  Burlington, Massachusetts, United States

Momentum stock picks flexion therapeutics kbr inc


Flexion Therapeutics is an American biotechnology company based in Burlington, Massachusetts that is developing long-lasting intra-articular injection therapies for the treatment of osteoarthritis. As of May 2012 Flexion was developing three new drug candidates:

  • FX005 is a sustained release, intra-articular p38 mitogen-activated protein kinase (p38 MAP) inhibitor,
  • Zilretta (FX006) is a sustained release, intra-articular steroid, that has received FDA Fast Track Designation to treat pain from osteoarthritis of the knee.
  • FX007 is a sustained release, intra-articular TrkA receptor antagonist.
  • References

    Flexion Therapeutics Wikipedia


    Similar Topics
    The Lost Special (serial)
    Fabiola Boulanger
    Diego Castro
    Topics
     
    B
    i
    Link
    H2
    L